Nursing Care for Patient with Multiple Drug Resistant Tuberculosis: A Case Study
Drug-resistant tuberculosis has increased leading to the development of therapeutic efficacy. Disinfectant treatment method with incorrect drug use or from chronic disease patients such as elderly patients, patients immunocompromised, etc. However, the lack of efficiency in the care of this patient caused additional treatment time and expenses. Therefore, nurses who have an important role need to have not only knowledge and understanding about drug-resistant tuberculosis, surveillance to prevent the spread of infection but also providing practical advice to promote health and well-being to reduce the severity of the disease and to monitor the progression of the disease. This article focuses on the nursing care of drug-resistant tuberculosis in terms of the nursing role in counseling, taking medication and adverse drug reactions, nutritional care, and social and economic support in the hospital, family and community.
Chang KC, Yew WW. Management of difficult multi-drug resistant tuberculosis and extensively
drug resistant tuberculosis: update 2012. Respirology 2013;18(1):8-21.
Caminero JA, editor. Guidelines for clinical and operational management of drugresistant
tuberculosis. Paris: International Union against Tuberculosis and Lung Diseases; 2013. p. 15-9.
World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis. Geneva, Switzerland: WHO; 2014: p.17-22.
Toman K. How many bacilli are present in a sputum specimen found positive by smear microcopy?. In: Frieden TR, editor. Toman’s tuberculosis: case detection, treatment and monitoring, 2nd ed. China: World Health Organization; 2004: p. 11-3.
Mitnick CD, McGee B, Peloquin CA. Tuberculosis pharmacotherapy: strategies to optimize patient care. Expert Opin Pharmacother 2009;10(3):381-401.
Chang KC, Yew WW, Tam CM, Leung CC. WHO group 5 drugs and difficult multidrugresistant tuberculosis: a systematic review with cohort analysis and meta-analysis. Antimicrob Agents Chemother 2013; 57(9):4097-104.
World Health Organization. Treatment of tuberculosis guidelines. 4th ed. Geneva, Switzerland: WHO; 2010.
World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis, emergency update 2008. Geneva, Switzerland: WHO; 2008.
Nakornchai S. Antimycobacterials. In: Uthiphat A, Sukvanich N, editors. Pharmacology, Volume 2. Bangkok: New Thai Mitr Printing (1996); 2000. p. 254-61. (in Thai)
Tansuwat S. The development of clinical care plans for prevention and control spreading tuberculosis in the outpatient department general hospital. Nursing journal 2014;41(4): 1-8. (in Thai)
Bureau of Tuberculosis. Department of Disease Control, Ministry of Public Health. Tuberculosis control guidelines in Thailand, 2018. Bangkok: Aksorn Graphic and Design Publisher; 2018. (in Thai)
เนื้อหาบทความหรือข้อคิดเห็นต่างๆ ในวารสารพยาบาลสภากาชาดไทยนี้ เป็นความคิดเห็นของผู้เขียนบทความ ไม่ใช่ความเห็นของกองบรรณาธิการ หรือสถาบันการพยาบาลศรีสวรินทิรา สภากาชาดไทย